MaxCyte
MXCT
#8743
Rank
A$0.24 B
Marketcap
A$2.33
Share price
0.00%
Change (1 day)
-64.18%
Change (1 year)

Revenue for MaxCyte (MXCT)

Revenue in 2025 (TTM): A$55.35 Million

According to MaxCyte's latest financial reports the company's current revenue (TTM ) is A$53.84 Million. In 2024 the company made a revenue of A$62.1 Million an increase over the revenue in the year 2023 that were of A$60.6 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for MaxCyte from 2021 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$55.35 M-10.86%
2024 A$62.1 M2.48%
2023 A$60.6 M-6.83%
2022 A$65.04 M39.12%
2021 A$46.75 M